Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 17/20 | 0.60 |
| ▸ | CA1 | P00915 | 16/20 | 0.60 |
| ▸ | MMP1 | P03956 | 6/20 | 0.60 |
| ▸ | MMP2 | P08253 | 6/20 | 0.60 |
| ▸ | MMP9 | P14780 | 6/20 | 0.60 |
| ▸ | MMP8 | P22894 | 6/20 | 0.60 |
| ▸ | MMP13 | P45452 | 6/20 | 0.60 |
| ▸ | F2 | P00734 | 3/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9069070 | 0.98 | CA2 (0.61) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL155317 | 0.98 | CA2 (0.61) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL8090495 | 0.98 | CA2 (0.61) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL9069081 | 0.98 | CA2 (0.61) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3145913 | 0.98 | CA2 (0.61) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3179140 | 0.92 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL10369251 | 0.92 | CA2 (0.48) | CA2CA1MMP1MMP2MMP9 | |
| Acetic Acid SCHEMBL28673417 | 0.88 | CA2 (0.57) | CA2CA1MMP1MMP2MMP9 | |
| Alcohol SCHEMBL11151356 | 0.88 | CA2 (0.57) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL30233534 | 0.82 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118421154-A | Environment-adaptive water-based durable short-chain fluorine-containing water-repellent oil-repellent paint, and preparation method and application thereof | 四川大学 | 2024-08-02 | — | — | CN | claimed |
| CN-117783362-A | Method for detecting content of perfluoro and polyfluoro compound | 中国计量科学研究院 | 2024-03-29 | — | — | CN | claimed |
| EP-4185555-B1 | PFAS TREATMENT PROCESS FOR LIQUID EFFLUENT | SUEZ INT (FR) | 2025-10-01 | — | — | EP | disclosed |
| US-12428384-B2 | Hydroxy-functionalized triazine compounds, curable fluoropolymer compositions comprising such compounds and cured articles therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-09-30 | — | — | US | disclosed |
| EP-4579235-A1 | METHOD FOR DETERMINATION OF CONCENTRATIONS OF PER- AND POLYFLUOROALKYL SUBSTANCES, AND LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY SYSTEM | Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences (CN) | 2025-07-02 | — | — | EP | disclosed |
| WO-2025072343-A1 | METHODS FOR THE DESTRUCTION OF POLYFLUORINATED ORGANIC COMPOUNDS | CYCLOPURE, INC. (US) | 2025-04-03 | — | — | WO | disclosed |
| US-20250099969-A1 | METHODS FOR THE DESTRUCTION OF POLYFLUORINATED ORGANIC COMPOUNDS | CYCLOPURE, INC. | 2025-03-27 | — | — | US | disclosed |
| EP-3824325-B1 | VEHICLE SENSORS COMPRISING REPELLENT SURFACE, PROTECTIVE FILMS, REPELLENT COATING COMPOSITIONS, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-01-08 | — | — | EP | disclosed |
| US-12186737-B2 | Regeneration of polymeric cyclodextrin adsorbents | CYCLOPURE, INC. (US) | 2025-01-07 | — | — | US | disclosed |
| US-20240293801-A1 | REGENERATION OF POLYMERIC CYCLODEXTRIN ADSORBENTS | AVENUE GLOBAL DISLOCATION OPPORTUNITIES FUND, L.P. AND AVENUE GLOBAL OPPORTUNITIES MASTER FUND, L.P. | 2024-09-05 | — | — | US | disclosed |
| EP-4419249-A1 | REGENERATION OF POLYMERIC CYCLODEXTRIN ADSORBENTS | Cyclopure, Inc. (US) | 2024-08-28 | — | — | EP | disclosed |
| US-5426205-A | Perfluoroalkylsulphonamidoalkoxysilanes | BAYER AKTIENGESELLSCHAFT (DE) | 1995-06-20 | — | — | US | disclosed |
| EP-0640611-A1 | Fluor containing alkoxysilanes | BAYER AG (DE) | 1995-03-01 | — | — | EP | disclosed |
| CN-1096788-A | The phosphono of hydroxyl and/or mercapto groups-and phosphinocarboxylic acid's fluorinated carboxylic ester class and its production and use | BAYER AG (DE) | 1994-12-28 | — | — | CN | disclosed |
| EP-0099990-B1 | PROCESS FOR THE PREPARATION OF POLYCARBONATES CONTAINING N-ALKYLPERFLUOROALKYL SULFON AMIDE END GROUPS | BAYER AG (DE) | 1986-01-15 | — | — | EP | disclosed |
| US-4503213-A | LOW MELT VISCOSITY MOLDING MATEERIALS | BAYER AKTIENGESELLSCHAFT (DE) | 1985-03-05 | — | — | US | disclosed |
| EP-0099990-A1 | Process for the preparation of polycarbonates containing N-alkylperfluoroalkyl sulfon amide end groups | BAYER AG (DE) | 1984-02-08 | — | — | EP | disclosed |
| EP-0007519-B1 | PROCESS FOR THE PREPARATION OF HYDROXYALKYL-PERFLUORALKANE-SULFONAMIDES | BAYER AG (DE) | 1981-11-04 | — | — | EP | disclosed |
| US-4265831-A | Process for the preparation of hydroxyalkylperfluoroalkane sulphonamides | BAYER AKTIENGESELLSCHAFT (DE) | 1981-05-05 | — | — | US | disclosed |
| EP-0007519-A1 | Process for the preparation of hydroxyalkyl-perfluoralkane-sulfonamides | BAYER AG (DE) | 1980-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428384-B2 | Hydroxy-functionalized triazine compounds, curable fluoropolymer compositions comprising such compounds and cured articles therefrom | ALKBH3, HDGF, UHRF1 | CA2 1121/4885CA1 757/4885MMP1 3462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.